RIABNI FDA approval date

The FDA approved RIABNI on 17 Dec 2020.

FDA approval date
17 Dec 2020

Drug identity has not yet been verified against registry records

Also recorded as RITUXIMAB-ARRX

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-12-17DayRIABNIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761140", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["RIABNI"], "active_ingredients": ["RITUXIMAB-ARRX"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20201217", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026